Stefan Pöhlmann

52.4k total citations · 11 hit papers
231 papers, 30.8k citations indexed

About

Stefan Pöhlmann is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Stefan Pöhlmann has authored 231 papers receiving a total of 30.8k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Infectious Diseases, 81 papers in Immunology and 69 papers in Epidemiology. Recurrent topics in Stefan Pöhlmann's work include SARS-CoV-2 and COVID-19 Research (92 papers), HIV Research and Treatment (58 papers) and COVID-19 Clinical Research Studies (46 papers). Stefan Pöhlmann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (92 papers), HIV Research and Treatment (58 papers) and COVID-19 Clinical Research Studies (46 papers). Stefan Pöhlmann collaborates with scholars based in Germany, United States and United Kingdom. Stefan Pöhlmann's co-authors include Markus Hoffmann, Hannah Kleine‐Weber, Christian Drosten, Nadine Krüger, Marcel A. Müller, Georg Herrler, Simon Schroeder, Tanja Herrler, Andreas Nitsche and Tobias S. Schiergens and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Stefan Pöhlmann

226 papers receiving 30.3k citations

Hit Papers

SARS-CoV-2 Cell Entry... 2003 2026 2010 2018 2020 2020 2011 2013 2021 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
    2020 13.3k citations Markus Hoffmann, Hannah Kleine‐Weber et al. Cell profile →
  2. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
    2020 1.2k citations Markus Hoffmann, Hannah Kleine‐Weber et al. profile →
  3. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
    2011 804 citations Marcel A. Müller, Christian Drosten et al. Journal of Virology profile →
  4. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
    2013 647 citations Adeline Heurich, Heike Hofmann-Winkler et al. Journal of Virology profile →
  5. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
    2021 563 citations Markus Hoffmann, Prerna Arora et al. Cell profile →
  6. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
    2021 557 citations Markus Hoffmann, Nadine Krüger et al. Cell profile →
  7. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
    2005 554 citations Stefan Pöhlmann et al. Proceedings of the National Academy of Sciences profile →
  8. Protease inhibitors targeting coronavirus and filovirus entry
    2015 437 citations Stefan Pöhlmann et al. profile →
  9. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
    2020 387 citations Daniel Wrapp, Dorien De Vlieger et al. Cell profile →
  10. Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
    2003 309 citations Stefan Pöhlmann et al. Journal of Virology profile →
  11. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
    2024 49 citations Amy Kempf, Inga Nehlmeier et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Pöhlmann Germany 64 21.3k 5.8k 5.5k 4.5k 3.9k 231 30.8k
Shibo Jiang China 86 19.6k 0.9× 6.9k 1.2× 4.1k 0.8× 1.7k 0.4× 4.3k 1.1× 496 28.8k
Michael Farzan United States 76 15.8k 0.7× 7.2k 1.2× 9.9k 1.8× 1.8k 0.4× 4.4k 1.1× 178 30.4k
Andreas Nitsche Germany 49 12.8k 0.6× 5.5k 1.0× 1.8k 0.3× 3.3k 0.7× 3.2k 0.8× 252 22.0k
Hyeryun Choe United States 56 11.7k 0.5× 5.0k 0.9× 7.5k 1.3× 1.4k 0.3× 2.5k 0.6× 97 22.8k
Marcel A. Müller Germany 58 23.9k 1.1× 4.8k 0.8× 2.4k 0.4× 4.6k 1.0× 3.2k 0.8× 140 31.4k
Zheng‐Li Shi China 53 17.7k 0.8× 3.5k 0.6× 2.4k 0.4× 2.2k 0.5× 2.1k 0.5× 246 23.8k
Bart L. Haagmans Netherlands 74 17.2k 0.8× 3.5k 0.6× 2.5k 0.5× 2.2k 0.5× 4.1k 1.0× 245 24.6k
Stanley Perlman United States 83 24.0k 1.1× 5.5k 0.9× 5.2k 0.9× 6.3k 1.4× 3.4k 0.9× 331 34.7k
Ralph S. Baric United States 103 34.2k 1.6× 6.3k 1.1× 4.1k 0.7× 4.0k 0.9× 4.3k 1.1× 464 43.9k
Barney S. Graham United States 87 15.6k 0.7× 5.9k 1.0× 7.2k 1.3× 986 0.2× 13.9k 3.5× 359 30.9k

Countries citing papers authored by Stefan Pöhlmann

Since Specialization
Citations

This map shows the geographic impact of Stefan Pöhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Pöhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Pöhlmann more than expected).

Fields of papers citing papers by Stefan Pöhlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Pöhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Pöhlmann. The network helps show where Stefan Pöhlmann may publish in the future.

Co-authorship network of co-authors of Stefan Pöhlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Pöhlmann. A scholar is included among the top collaborators of Stefan Pöhlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Pöhlmann. Stefan Pöhlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Gavin J., Amy Kempf, Inga Nehlmeier, et al.. (2025). Polyvalent Mannuronic Acid-Coated Gold Nanoparticles for Probing Multivalent Lectin–Glycan Interaction and Blocking Virus Infection. Viruses. 17(8). 1066–1066.
2.
Hempel, Tim, Jonathan H. Shrimp, Nina Moor, et al.. (2025). Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor. Nature Communications. 16(1). 6949–6949.
3.
Nowak, Rafał, et al.. (2024). TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses. Virology. 600. 110218–110218. 2 indexed citations
4.
Sun, Ting, et al.. (2024). Development of rhesus macaque astrocyte cell lines supporting infection with a panel of viruses. PLoS ONE. 19(5). e0303059–e0303059.
5.
6.
Jacobsen, Henning, Markus Hoffmann, Amy Kempf, et al.. (2023). TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection. Viruses. 15(2). 271–271. 38 indexed citations
7.
Gärtner, Sabine, et al.. (2023). Development of immortalized rhesus macaque kidney cells supporting infection with a panel of viruses. PLoS ONE. 18(5). e0284048–e0284048. 2 indexed citations
8.
Wressnigg, Nina, Susanne Eder-Lingelbach, Anders Lilja, et al.. (2023). EFFECTS OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER VACCINATIONS OF THE INACTIVATED DUAL-ADJUVANTED VACCINE VLA2001 AGAINST COVID-19 INCLUDING VARIANTS OF CONCERN: A PHASE 3 RANDOMIZED CLINICAL TRIAL. International Journal of Infectious Diseases. 130. S25–S25. 1 indexed citations
9.
Wagoner, Jessica, Tien-Ying Hsiang, Aleksandr Ianevski, et al.. (2022). Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2. Microbiology Spectrum. 10(5). e0333122–e0333122. 34 indexed citations
10.
Gärtner, Sabine, et al.. (2022). A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2. Viruses. 14(1). 91–91. 1 indexed citations
11.
Sidarovich, Anzhalika, Nadine Krüger, Cheila Rocha, et al.. (2022). Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1. Viruses. 14(11). 2475–2475. 1 indexed citations
12.
Chaudhry, M. Zeeshan, Kathrin Eschke, Markus Hoffmann, et al.. (2022). Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases. Journal of Virology. 96(5). e0218621–e0218621. 24 indexed citations
13.
Wettstein, Lukas, Christian Kersten, Tatjana Weil, et al.. (2022). Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture. Communications Biology. 5(1). 681–681. 17 indexed citations
14.
Hammerschmidt, Swantje I., Berislav Bošnjak, Günter Bernhardt, et al.. (2021). Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination. Cellular and Molecular Immunology. 18(10). 2455–2456. 29 indexed citations
15.
Schroeder, Simon, Christin Mache, Hannah Kleine‐Weber, et al.. (2021). Functional comparison of MERS-coronavirus lineages reveals increased replicative fitness of the recombinant lineage 5. Nature Communications. 12(1). 5324–5324. 15 indexed citations
16.
Hayn, Manuel, Armando Rodríguez, Solange Vidal, et al.. (2021). Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling. Proceedings of the National Academy of Sciences. 118(3). 12 indexed citations
17.
Hoffmann, Markus, Heike Hofmann-Winkler, Nadine Krüger, et al.. (2021). SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Reports. 36(3). 109415–109415. 162 indexed citations
18.
Wrapp, Daniel, Dorien De Vlieger, Kizzmekia S. Corbett, et al.. (2020). Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 181(5). 1004–1015.e15. 387 indexed citations breakdown →
19.
Gerlach, Thomas, Luca Hensen, Tatyana Matrosovich, et al.. (2017). pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs. Journal of Virology. 91(11). 52 indexed citations
20.
Heurich, Adeline, Heike Hofmann-Winkler, Stefanie Gierer, et al.. (2013). TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein. Journal of Virology. 88(2). 1293–1307. 647 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shibo Jiang Breakdown of academic impact, for papers by Michael Farzan Breakdown of academic impact, for papers by Andreas Nitsche Breakdown of academic impact, for papers by Hyeryun Choe Breakdown of academic impact, for papers by Marcel A. Müller Breakdown of academic impact, for papers by Zheng‐Li Shi Breakdown of academic impact, for papers by Bart L. Haagmans Breakdown of academic impact, for papers by Stanley Perlman Breakdown of academic impact, for papers by Ralph S. Baric Breakdown of academic impact, for papers by Barney S. Graham
Rankless by CCL
2026